TRIP 13-dependent pathways promote the development of gastric cancer.

"Declarations Competing interestsThe authors declare no competing interests. Ethics approval and consent participateThe experimental protocols were approved by the Ethics Committee of the First Hospital of Jilin University (SYXK (JI)2022–0002). No patients were involved in this study. Animal ethicsThe experimental procedure followed the US National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85–23, revised 1985). The study protocol was approved by the First Hospital of Jilin University (SYXK (JI)2022–0002). Conflict of interestThe authors declare no competing interests. Competing interests The authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding This work was supported by the Jilin Provincial Finance Department (No. JLSWSRCZX2020-006) and the National Natural Science Foundation of China (No. 3A417E013428)."